New Delhi, June 26 -- A new study from the University of Notre Dame in the United States has revealed something deeply worrying: many cancer patients in sub-Saharan Africa may not be getting the treatment they truly need. According to the research, one out of every six cancer medications tested in countries like Kenya, Malawi, Ethiopia, and Cameroon was found to be of poor quality.

Some drugs had far too little of the 'active ingredient', the part that actually treats cancer. Others had too much, which could be harmful. The safe range for these ingredients is between 90 per cent and 110 per cent of what's written on the label. But researchers found medicines with as little as 28 per cent and as high as 120 per cent.

This means that if a...